This study successfully constructed a prognostic model for HBV-HCC comprising G6PD, PINK1, and LGALS3, and analyzed the key role of LGALS3 in adverse disease progression after HBV persistence infection. The gene discussed is LGALS3; the disease is hepatocellular carcinoma.